In 2014, an outside panel of experts urged the FDA to tighten the language on testosterone-replacement drug labels to limit the medicines from being overprescribed and rein in the aggressive marketing by drug-makers.
According to the FDA, the benefits of testosterone drugs for healthy, aging men are unproven, and the drugs could be risky.